(esketamine)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SPRAVATO® (esketamine)
Medical Information
Clinical Trials of SPRAVATO in Patients with Major Depressive Disorder and Active Suicidal Ideation with Intent Slide Deck
Last Updated: 05/23/2025
SUMMARY
The following Esketamine Clinical Trials in Patients with Major Depressive Disorder and Active Suicidal Ideation with Intent Slide Deck is being provided to you in response to your unsolicited request.
Clinical Trials in Patients with Major Depressive Disorder and Active Suicidal Ideation with Intent Slide Deck
These slides are not intended as an endorsement or promotion of any usage not contained in the SPRAVATO Full Prescribing Information.1
An electronic copy of the slide deck may be accessed by clicking the hyperlink provided below. The content in the deck is not intended for modification.
References
| 1 | SPRAVATO (esketamine nasal spray) [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://imedicalknowledge.veevavault.com/ui/approved_viewer?token=7994-21c864d4-b928-49c5-b101-4d34e95f2be3. |